Covid-19 Booster Shots of Moderna and Pfizer Gets US FDA Clearance for US Adults

The US FDA, which has been the federal agency that has been responsible for the supervision and control of the novel corona virus disease, has given the clearance to the corona virus vaccine booster shots, that had been manufactured by the Modern and Pfizer to all the adults in the United States, along with expanding the campaign of the US government for protecting and getting ahead of the increasing infections that might get worse with the holidays.

The latest decision taken by the US FDA has been implied to either Moderna or Pfizer corona virus vaccine booster shots that can now be administered to any adult who is above 18 years of age after six months of their second dose of the vaccine. Although, the decision of the US CDC is still remained as it yet agree to the expansion of the corona virus vaccine boosters developed by Pfizer and Moderna even to the young and healthy people of the United States.

An advisory panel, who has been advising the US CDC on the corona virus vaccine policies are now expected for reviewing the evidence along with making any further guidance for the purpose of administering the corona virus vaccine booster shots. If the US CDC approves the booster shots then, around tens of millions of people in the United States can possibly have three doses of the protection from the corona virus before 2023 begins, and the people who had received the single-dose vaccine of Johnson and Johnson can also get a booster shot.